Skip to main content
Top
Published in: Reactions Weekly 1/2020

01-05-2020 | NSCLC | Case report

Osimertinib

Drug resistance: 7 case reports

Published in: Reactions Weekly | Issue 1/2020

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Buttitta F, et al. Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: A new algorithm for patient selection and personalized treatment. Oncotarget 11: 982-991, No. 11, 17 Mar 2020. Available from: URL: http://doi.org/10.18632/oncotarget.27517 Buttitta F, et al. Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: A new algorithm for patient selection and personalized treatment. Oncotarget 11: 982-991, No. 11, 17 Mar 2020. Available from: URL: http://​doi.​org/​10.​18632/​oncotarget.​27517
Metadata
Title
Osimertinib
Drug resistance: 7 case reports
Publication date
01-05-2020
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-78938-6

Other articles of this Issue 1/2020

Reactions Weekly 1/2020 Go to the issue

Case report

Methadone

Case report

Multiple drugs

Case report

Nivolumab

Case report

Tocilizumab